Global Innovative Platforms Inc. (GIPL): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$560.7K
Year ended 2025-09-30
-$335.2K
Trailing 12 months to 2026-06-30
$2622021-09-30: $2622022-09-30: -$53.6K2023-09-30: -$234.8K2024-09-30: -$87.4K2025-09-30: -$560.7K-$560.7K
2021-09-30 Operating Cash Flow (USD) 2025-09-30
Period endedOperating Cash FlowChange YoYSource filing
2025-09-30-$560.7Kn/m2026-01-13, From 2024-10-01
2024-09-30-$87.4Kn/m2026-01-13, From 2023-10-01
2023-09-30-$234.8Kn/m2024-12-30, From 2022-10-01
2022-09-30-$53.6Kn/m2024-08-23, From 2021-10-01
2021-09-30$262n/a2023-03-10, From 2020-10-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Global Innovative Platforms Inc. (GIPL)2025-09-30-$560.7Kn/m
Baxter International Inc (BAX)2025-12-31$845.00M-17.1%
Becton Dickinson & Co (BDX)2025-09-30$3.43B-10.8%
3M Co (MMM)2025-12-31$2.31B+26.8%
Teleflex Inc (TFX)2025-12-31$96.68M-68.0%
West Pharmaceutical Services Inc (WST)2025-12-31$754.80M+15.5%
Stryker Corp (SYK)2025-12-31$5.04B+18.9%
Haemonetics Corp (HAE)2026-03-28$293.22M+61.4%
KORU Medical Systems, Inc. (KRMD)2025-12-31$462.4Kn/m

Compare GIPL, BAX, BDX, MMM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗